ZOTA

Zota Healthcare Share Price

₹549.45 -5.3 (-0.96%)

21 Nov, 2024 14:04

SIP TrendupStart SIP in ZOTA

Start SIP

Performance

  • Low
  • ₹540
  • High
  • ₹555
  • 52 Week Low
  • ₹400
  • 52 Week High
  • ₹725
  • Open Price₹555
  • Previous Close₹555
  • Volume7,545

Investment Returns

  • Over 1 Month -10.54%
  • Over 3 Month -17.45%
  • Over 6 Month + 14.68%
  • Over 1 Year + 31.34%
SIP Lightning

Smart Investing Starts Here Start SIP with Zota Healthcare for Steady Growth!

Invest Now

Zota Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -43.4
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 1,506
  • P/B Ratio
  • 16.7
  • Average True Range
  • 18.37
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -10.64
  • RSI
  • 29.85
  • MFI
  • 25.59

Zota Healthcare Financials

Zota Healthcare Technicals

EMA & SMA

Current Price
₹549.45
-5.3 (-0.96%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹587.44
  • 50 Day
  • ₹604.79
  • 100 Day
  • ₹599.54
  • 200 Day
  • ₹563.38

Resistance and Support

553.22 Pivot Speed
  • R3 606.33
  • R2 588.12
  • R1 571.43
  • S1 536.53
  • S2 518.32
  • S3 501.63

What's your outlook on Zota Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Zota Healthcare Ltd. manufactures and markets pharmaceutical formulations, including tablets, capsules, and syrups. The company operates in India and exports to international markets, offering a wide range of affordable medicines for healthcare, wellness, and nutritional needs.

Zota Health Care Ltd has an operating revenue of Rs. 220.14 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of -9% needs improvement, ROE of -15% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 1 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Zota Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Others To consider other business matters. final dividend at the rate of 10 % i.e. Re. 1/- per equity share for the financial year 2019-20.
2024-08-14 Quarterly Results
2023-05-30 Audited Results & Dividend
2023-02-13 Quarterly Results
2023-01-11 Others Other business matters final dividend at the rate of 10 % i.e. Re. 1/- per equity share for the financial year 2019-20.

Zota Healthcare F&O

Zota Healthcare Shareholding Pattern

62.4%
0.01%
25.43%
0%

About Zota Healthcare

  • NSE Symbol
  • ZOTA
  • BSE Symbol
  • Managing Director
  • Mr. Moxesh Ketanbhai Zota
  • ISIN
  • INE358U01012

Similar Stocks to Zota Healthcare

Zota Healthcare FAQs

Zota Healthcare share price is ₹549 As on 21 November, 2024 | 13:50

The Market Cap of Zota Healthcare is ₹1505.9 Cr As on 21 November, 2024 | 13:50

The P/E ratio of Zota Healthcare is -43.4 As on 21 November, 2024 | 13:50

The PB ratio of Zota Healthcare is 16.7 As on 21 November, 2024 | 13:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23